HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Corazza Selected Research

Vulvar Lichen Sclerosus

6/2016Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial.
12/2015Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial.
6/2015Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: results of efficacy and tolerability.
1/2015Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus.
8/2014First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability.
7/2014Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients.
6/2013Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Corazza Research Topics

Disease

7Vulvar Lichen Sclerosus
06/2016 - 06/2013
3Hidradenitis Suppurativa
01/2021 - 11/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
10/2019 - 01/2003
2Atopic Dermatitis (Atopic Eczema)
08/2022 - 04/2021
2Contact Dermatitis (Eczema, Contact)
04/2001 - 10/2000
1Eczema
08/2022
1COVID-19
08/2022
1Erythema Nodosum
05/2022
1Sarcoidosis (Schaumann Disease)
09/2021
1Vitiligo
09/2021
1Acne Vulgaris
09/2019
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2015
1Herpes Zoster
05/2010
1Pain (Aches)
02/2010
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2003
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2003
1Nicolau Syndrome
11/2001
1Cicatrix (Scar)
11/2001
1Syphilis
11/2001
1Allergic Contact Dermatitis
11/2001
1Skin Diseases (Skin Disease)
10/2000
1Hypersensitivity (Allergy)
10/2000

Drug/Important Bio-Agent (IBA)

6Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 10/2000
5Mometasone Furoate (Nasonex)FDA LinkGeneric
06/2016 - 07/2014
2dupilumabIBA
08/2022 - 04/2021
2Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2016 - 01/2003
2Clobetasol (Clobetasol Propionate)FDA LinkGeneric
06/2016 - 08/2014
2Ointments (Pastes)IBA
06/2016 - 07/2014
1COVID-19 VaccinesIBA
05/2022
1Clindamycin (Cleocin)FDA LinkGeneric
01/2021
1Rifampin (Rifampicin)FDA LinkGeneric
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
05/2019
1Adalimumab (Humira)FDA Link
11/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2016
1ProcalcitoninIBA
11/2015
1Herpes Zoster VaccineIBA
05/2010
1methyl glucose dioleateIBA
11/2001
1BismuthIBA
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1PlasticsIBA
11/2001
1SaltsIBA
11/2001
1Proteins (Proteins, Gene)FDA Link
04/2001
1hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric
10/2000
1Budesonide (Pulmicort)FDA LinkGeneric
10/2000
1SteroidsIBA
10/2000

Therapy/Procedure

5Therapeutics
04/2021 - 01/2003
1Tattooing
09/2021
1Biological Therapy
10/2019
1Photochemotherapy (Photodynamic Therapy)
02/2010
1Debridement
11/2001
1Injections
11/2001
1Intramuscular Injections
11/2001